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Abstract
Background: In order to be widely accepted by users, the implementation of a new health intervention requires them 
to be adequately informed about its clinical importance, benefits and risks. The aim of this study was to provide data on 
the knowledge of Italian adolescents and parents concerning human papillomavirus (HPV) infection and its prevention 
in order to allow the development of adequate training programmes.
Methods: Between 2 May and 15 June 2008, we made a cross-sectional survey of 863 high school students and 2,331 
parents of middle and high school students using two anonymously completed questionnaires covering the 
knowledge of HPV infection and related diseases, and attitudes to vaccinations. The approached schools were a 
convenience sample of the schools of the greater Milan area, Northern Italy.
Results: More mothers than fathers were aware that HPV infection could concern their children (58% vs 53%; p = 0.004) 
and were favourable towards vaccinating their children against HPV (68% vs 65%; p = 0.03); among the students, more 
females than males were aware that HPV infection could concern themselves (45% vs 26%; p < 0.001) and would 
undergo vaccination against HPV (68% vs 40%; p < 0.001). The parents' propensity to vaccinate their children against 
HPV was significantly associated with professing the Catholic religion (odds ratio - OR = 0.61, 95% confidence interval - 
CI 0.46-0.82, being atheist), the gender of the offspring (OR = 1.88, 95% CI 1.53-2.30, having at least one daughter), a 
propensity to vaccinations in general (OR = 23.1, 95% CI 13.7-38.8), a knowledge that HPV vaccine is aimed at 
preventing cervical cancer (OR = 2.31, 95% CI 1.69-3.16), and an awareness that HPV could affect their own children (OR 
= 3.52, 95% CI 2.89-4.29). The students who were aware that HPV infection could affect themselves were more in favour 
of to HPV vaccination, regardless of whether they were male (OR = 5.73, 95% CI 2.85-11.5) or female (OR = 2.39, 95% CI 
1.66-3.46).
Conclusions: Both students and parents seem to underestimate the likelihood of HPV infection, and this is associated 
with a lower propensity for vaccination. This is an important indication for future training programmes concerning HPV 
prevention designed to increase the acceptance of HPV vaccine in families.
Background
Persistent infection with high-risk human papillomavirus
(HPV) can cause cancers of the cervix and other genital
sites, anus, oral cavity and oropharynx, and possibly the
larynx and skin [1-6].
In March 2008, the Italian Ministry of Health suggested
to the Vaccine Committee of the Regions to start an
active, free vaccination campaign against HPV as cause of
cervical cancer aimed at 12-year old girls in line with the
guidelines of a number of other industrialised countries
[7,8]. The choice of this age was based on findings that
HPV infection is almost exclusively due to sexual contact,
that a large proportion of subjects are first infected dur-
ing adolescence or early adulthood [9,10], and that the
immune response to HPV vaccination is higher in
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younger subjects [11]. Moreover, the available vaccines
against HPV types 16 and 18 (i.e. those associated with
the highest risk of cancer) have no therapeutic effect
against already established infection and HPV-associated
diseases [12]. However, HPV vaccination is also indicated
in older teenagers who have not yet (or have only just)
started sexual activity, and might even be considered in
women aged more than 25 years [11,13,14]. This explains
why some Italian Regions, although maintained cervical
cancer prevention as the primary purpose of prevention
programme, extended the free vaccination campaign to
young people aged 15 or 16 years, and others are offering
older teenagers a discount on the price of HPV vaccina-
tion.
In order to be widely accepted by users, the implemen-
tation of a new health intervention requires them to be
adequately informed about its clinical importance, bene-
fits and risks. HPV vaccination is more complex than
other health initiatives because the targets are young,
decisions are generally made by their parents, and may
not be based on reliable information. Moreover, even
when younger subjects are still being followed by pedia-
tricians, the physicians may be poorly informed about
HPV-related diseases because most of these occur in
adulthood [15]. In order to be successful, HPV vaccina-
tion programmes therefore need to educate not only the
targets, but also their parents and healthcare providers.
This means previously acquiring adequate information
concerning the knowledge and attitudes of the different
subjects involved. A number of investigations carried out
in different parts of the world have shown that such sub-
jects are inadequately aware of the problem [15-22],
although most of the surveys of adults' knowledge of
HPV did not focus on their parental role. Furthermore,
little information is available concerning Italian teenag-
ers' and parents' knowledge of, and attitude towards HPV
infection and its prevention [18,19]. Considering the
importance of communication and educational material
in improving vaccination coverage [23-26], the aim of this
study of a large number of high school students and par-
ents of middle and high school students was to provide
some of the basic data necessary for the development of
adequate training programs.
Methods
Between 2 May and 15 June 2008, we carried out a cross-
sectional survey of high school students and parents of
middle and high school students in order to verify their
knowledge of HPV infection and HPV-related diseases,
and their attitudes to vaccinations (particularly HPV vac-
cine).
The survey involved two middle schools in Milan (one
private and one state run), five high schools specialising
in classical, linguistic or scientific studies (two private
and three state run) in the greater Milan area and Varese,
and one state-run technical school in Milan. The schools
were a convenience sample chosen on the basis of con-
tacts of the authors of this paper with school boards. We
varied the type of schools included in the investigation in
order to obtain a composite distribution of subjects
reflecting the characteristics of the baseline population,
with specific reference to age of the students and educa-
tional level of the parents. S.E. and N.P. had repeated con-
tacts with boards of each school before the distribution of
the questionnaires in order to assure the best compliance
of teachers to the survey. After the study had been
approved by the Ethics Committee of Fondazione IRCCS
Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy,
and the boards of each school, all of the students attend-
ing the high schools were given three questionnaires: one
for the student and one for each parent. Because of the
age of the students attending the middle schools (10-13
years), school boards decided that only their parents had
to complete a questionnaire.
The students' and parents' questionnaires were
designed to collect information concerning the compilers'
knowledge of HPV infection and their attitudes to vacci-
nation. Both were to be anonymously self-completed (at
home), and were accompanied by a formal letter describ-
ing the aims of the study and explaining how to complete
the questionnaires. The same information was also given
orally when the questionnaires were given to the stu-
dents.
The questionnaires, that were prepared by a multidisci-
plinary group including pediatricians (SE, NP) and epide-
miologists (CP, CG), were pilot-tested on a convenience
sample of adolescents and parents attending the outpa-
tient clinic of the Fondazione IRCCS Ca' Granda Osped-
ale Maggiore Policlinico in Milan in order to ensure
clarity and ease of administration. The student question-
naire [Additional file 1] had four sections covering: 1)
demographic and socio-economic characteristics such as
age, race, religion, number of siblings, and the education
and occupation of the parents; 2) HPV infection (its per-
ceived dangerousness and modes of transmission) and
vaccination (including preventable diseases, age at vacci-
nation, and favourite source of vaccine information); 3)
their willingness to be vaccinated against HPV; and 4)
their sexual activity and attitudes to discussing sexual
health issues. The parent questionnaire [Additional file 2]
had five sections covering: 1) demographic and socio-
economic characteristics such as age, race, religion, num-
ber and age of children, education and occupation, and
family history of cancer; 2) attitudes towards vaccinations
in general; 3) HPV infection and HPV vaccination; 4)
their willingness to have their children vaccinated against
HPV; and 5) their attitudes to discussing sexual health
issues with their children and informing them about HPVPelucchi et al. BMC Public Health 2010, 10:378
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infection and vaccination. The items for students were
presented in an easier way, but covered aspects similar to
that asked to the parents.
The students had to return the questionnaires to their
teachers within a week of their distribution, and the com-
pleted questionnaires were collected from the schools by
members of the research team.
The responses were analysed by means of descriptive
statistics. In the case of categorical data, the gender
groups (mothers vs fathers among parents and females vs
males among students) were compared using the χ2 or
Fisher's exact test as appropriate. All of the analyses were
two tailed, and p values of 0.05 or less were considered
significant. Odds ratios (OR) and 95% confidence inter-
vals (CI) were calculated in order to measure the associa-
tions between selected factors chosen on the basis of
literature review and the parents' propensity to have their
children vaccinated against HPV, or the students' propen-
sity to undergo HPV vaccination themselves. The ORs
were obtained by means of unconditional multiple logis-
tic regression adjusted for: 1) age, education, gender and
religion of the parents, and age and gender of their chil-
dren in the case of the parents' data; or 2) age and religion
of the student and education of the parents in the case of
the students' data. All of the analyses were made using
SAS version 9.1 (Cary, NC, USA).
Results and discussion
A total of 3,026 questionnaires were distributed to par-
ents (1,520 to mothers and 1,506 to fathers), 2,331
(77.0%) of which were returned with more than 70% of
the questions answered. The students received a total of
1,092 questionnaires (691 given to females and 401 to
males), 863 (79.0%) of which were returned with more
than 70% of the questions answered. There was no differ-
ence in the response rates of the mothers and fathers,
whereas female students answered significantly more fre-
quently than male students (93.9% vs 52.1%; p < 0.0001).
There was also no significant difference in response rates
and data obtained in the different schools.
Table 1 shows the distribution of the 2,331 parents who
participated in the survey on the basis of selected socio-
demographic characteristics. Fathers were older than
mothers: respectively 44% and 23% were aged 50 years.
Forty-one percent of the parents had a university degree.
Twenty-three percent had only one child, 56% two chil-
dren, and 21% three or more; 11% had at least one child
aged <12 years, while the modal age of their children was
16-17 years (32%). Most of the parents had at least one
daughter involved in the survey (72%).
Table 2 shows the distribution of the 863 students par-
ticipating in the survey on the basis of selected socio-
demographic characteristics. Age distribution was similar
among the males and females: the age range was 14-20
years, and the mean age 16.1 years. Most had only one
sibling (55%), or were the only child in the family (22%).
Table 3 shows the distribution of the parents' and stu-
dents' answers concerning their personal knowledge of
HPV infection and vaccination, by gender. Mothers had
ever heard of HPV more frequently than fathers (91% vs
77%; p < 0.001) and, among the parents who were aware
of HPV, the mothers were also more often aware of the
dangerousness of the virus (92% vs 88%; p = 0.004) and
more informed as to how it is transmitted (94% vs 91%; p
= 0.02). Similarly, a higher proportion of female (72%)
than male students (51%; p < 0.001) had ever heard of
HPV but, among those who were aware of HPV, there
was no significant gender-related difference in its per-
ceived dangerousness (about 90% in both sexes) or how it
is transmitted (90% vs  92%). With reference to their
knowledge of HPV vaccination, 90% of the mothers and
87% of the fathers knew that HPV vaccine is aimed at pre-
venting cervical cancer (p = 0.02); the corresponding fig-
ures for the female and male students were 75% and 63%
(p = 0.008). About 75% of the mothers, fathers and female
students knew that the vaccination should be given
before sexual activity begins; this decreased to 67% of the
male students, although the between-gender difference
among the students was not significant.
Table 4 shows the attitudes of the parents and students
to vaccination (only the parents were asked questions
about vaccinations in general: i.e. not specific to HPV).
Both mothers (92%) and fathers (93%) were generally in
favour of vaccinations. When asked which recommenda-
tions were more important when deciding whether to
have their children vaccinate, they more frequently indi-
cated the Ministry of Health (about 48% of both mother
and fathers), pediatricians (50% of mothers, 43% of
fathers, p = 0.001) and other physicians (28% of mothers,
24% of fathers). The mothers were more aware than the
fathers that HPV infection could affect their children
(58% vs 53%, p = 0.004) and were more in favour of them
being vaccinated (68% vs 65%; p = 0.03). When these last
two questions were answered by the students, 45% of
females and 26% of males were aware that HPV infection
could concern themselves (p < 0.001), and 68% of females
and 40% of males said they would undergo HPV vaccina-
tion (p < 0.001).
Table 5 shows the associations among the parents
between selected factors and their attitude to HPV vacci-
nation for their children. There was no significant associ-
ation between the propensity to have their children
vaccinated and the age, gender or education of the parent,
or the age of their children. The parents professing a reli-
gion other than Catholicism or who were atheists were
less in favour of HPV vaccination for their children (OR =
0.61, 95% CI 0.46-0.82, compared with Catholics). Signifi-
cant associations with a propensity to have their childrenPelucchi et al. BMC Public Health 2010, 10:378
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vaccinated also included the gender of the offspring (OR
= 1.88, 95% CI 1.53-2.30, having at least one daughter), a
propensity to vaccinations in general (OR = 23.1, 95% CI
13.7-38.8), a knowledge that HPV vaccine is aimed at pre-
venting cervical cancer (OR = 2.31, 95% CI 1.69-3.16),
and an awareness that HPV could affect their own chil-
dren (OR = 3.52, 95% CI 2.89-4.29).
Table 6 shows the associations among students, by gen-
der. The age and religion of the student, and the educa-
tional level of their parents were not associated with a
propensity to HPV vaccination in either the male or
female students. The students who were aware that HPV
infection could affect themselves were more in favour of
to HPV vaccination, regardless of whether they were male
(OR = 5.73, 95% CI 2.85-11.5) or female (OR = 2.39, 95%
CI 1.66-3.46). The female students who declared they had
a boyfriend (OR = 0.67, 95% CI 0.47-0.97) and had
already experienced sexual intercourse (OR = 0.68, 95%
Table 1: Distribution of parents by gender, age and selected socio-demographic characteristics
Mothers (n = 1225) Fathers (n = 1093) All (n = 2331)a
No. % No. %N o .%
Age (years)
<40 93 7.6 37 3.4 130 5.6
40-44 348 28.4 173 15.8 521 22.4
45-49 488 39.8 390 35.7 885 38.0
≥50 282 23.0 476 43.5 759 32.5
Missing values 14 1.2 17 1.6 36 1.5
Mean age ± SD (years) 46.1 ± 5.6 49.1 ± 5.6 47.5 ± 5.4
Education
Middle school diploma 176 14.4 222 20.3 398 17.1
High school diploma 564 46.0 406 37.0 973 41.7
Degree 475 38.8 462 42.4 944 40.5
Missing values 10 0.8 3 0.3 16 0.7
No. of children
1 292 23.8 249 22.8 544 23.3
2 681 55.6 610 55.8 1296 55.6
3 198 16.2 180 16.5 380 16.4
≥4 50 4.1 52 4.8 103 4.4
M i s s i n g  v a l u e s 40 . 320 . 180 . 3
Age of child(ren) involved in the study b (years)
<12 143 11.7 118 10.8 261 11.2
12-13 262 21.4 236 21.6 501 21.5
14-15 303 24.7 278 25.4 582 25.0
16-17 384 31.3 337 30.8 725 31.1
≥18 112 9.2 105 9.7 220 9.4
Missing values 21 1.7 19 1.7 42 1.8
Gender of child(ren) involved in the study
Male 341 27.8 298 27.3 641 27.5
Female 821 67.0 719 65.8 1549 66.5
Both 57 4.7 65 5.9 122 5.2
Missing values 6 0.5 11 1.0 19 0.8
SD, standard deviation. a Thirteen parents did not answer the question concerning gender. b When more than one offspring was involved, the 
age of the youngest is given.Pelucchi et al. BMC Public Health 2010, 10:378
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CI 0.44-1.03) were less in favour of HPV vaccination,
whereas these factors were not associated with the pro-
pensity to undergo vaccination among the male students.
There was no significant association with a knowledge
that HPV vaccine is aimed at preventing cervical cancer.
This study of an upper-middle class population in the
greater Milan area, Northern Italy, found that teenagers
and parents still have a number of gaps in their knowl-
edge of HPV infection and its prevention by means of
vaccination. In particular, they seemed to underestimate
the likelihood of HPV infection and were therefore less
likely to see HPV vaccination favourably. This is an
important indication for future family HPV training pro-
grammes designed to increase the acceptance of HPV
vaccination.
Most of the parents were aware of HPV and correctly
answered a number of questions about it. This might be
at least partially explained by their higher education level
in Northern Italy in comparison with the general Italian
population [27]. There are relatively few other studies of
parents, most of which have found a lower level of knowl-
edge of HPV infection. A previous Italian study per-
formed in Southern Italy found that 54% of the mothers
of daughters aged 10-12 years had ever heard of HPV
[19], and the corresponding figure in a school-based sur-
vey conducted in four areas of England was only 26% [28].
However, a US (North Carolina) study reported findings
close to ours, with an 83% awareness of HPV among care-
givers (mostly parents) and a 69% average of correct
answers to questions about it [29].
Nevertheless, a proportion of our parents still need to
be better informed about HPV-related health topics. The
facts that parents, who are key decision makers in the
u p t a k e  o f  t h i s  v a c c i n e ,  a r e  s t i l l  h e s i t a n t  t o  h a v e  t h e i r
daughters receive HPV vaccine, and that strategies to
ensure optimal HPV vaccine uptake need to be employed
have been recently reported in a population-based evalu-
ation in British Columbia, Canada [30]. In our study, this
Table 2: Distribution of students by gender, age and selected socio-demographic characteristics
Females
(n = 649)
Males
(n = 209)
All
(n = 863)a
No. % No. % No. %
Age (years)
14-15 231 35.6 85 40.7 317 36.7
16-17 309 47.6 92 44.0 402 46.6
≥18 107 16.5 30 14.3 137 15.9
M i s s i n g  v a l u e s 20 . 321 . 070 . 8
Mean age ± SD (years) 16.2 ± 1.44 16.0 ± 1.59 16.1 ± 1.48
Education (mother)
Middle school diploma 133 20.5 28 13.4 161 18.7
High school diploma 312 48.1 93 44.5 408 47.3
Degree 191 29.4 85 40.7 278 32.1
Missing values 13 2.0 3 1.4 16 1.9
Education (father)
Middle school diploma 148 22.8 32 15.3 180 20.9
High school diploma 242 37.3 62 29.7 308 35.7
Degree 239 36.8 108 51.7 348 40.3
Missing values 20 3.1 7 3.3 27 3.1
No. of siblings
0 150 23.1 41 19.6 194 22.5
1 359 55.3 115 55.0 476 55.2
2 104 16.1 38 18.2 142 16.4
≥3 36 5.5 15 7.2 51 5.9
SD, standard deviation. a Five students did not answer the question concerning gender.Pelucchi et al. BMC Public Health 2010, 10:378
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was especially true for the fathers, whose overall knowl-
edge of HPV (including awareness of HPV infection and
its dangerousness, despite in some cases these differences
were marginal and not clinically relevant) was signifi-
cantly less than that of the mothers. Once again, our find-
ings were comparable with those of the North Carolina
investigation, which found that only 54% of male caregiv-
ers knew about HPV as against 84% of female caregivers
[29]. Our findings indicate that interventions aimed at
increasing knowledge of HPV should involve the fathers
of young children, not least because any health procedure
in pediatric subjects must be authorised by both parents
in Italy.
Among the students, about 70% of the females and 50%
of the males had ever heard of HPV, and about 75% of the
former and 66% of the latter know about the aim and
mode of HPV vaccination. The data from other studies
are mixed [18,31-34]. A cross sectional study of females
aged 14-24 years carried out in Southern Italy found that
only 30% had ever heard of HPV infection [18], and that
the proportion of women who were aware that HPV vac-
cination is aimed at preventing cervical cancer was also
low [18]. In a recent Swedish survey [35], only 5% of the
first-year high students of both sexes were aware of HPV,
whereas a 1999 study of US university students found that
37% of the respondents had ever heard of it [36].
However, although our findings indicated a better
knowledge of HPV among students, it is of concern that
only 45% of the female teenagers perceived themselves at
risk of HPV infection. This might be explained by a lack
of awareness of the high prevalence of HPV infection
[9,35], as has been previously found in other studies
[37,38]. Furthermore, in addition to having less knowl-
edge of HPV, a large proportion of the male students
thought that it did not concern them. This is maybe not
surprising as HPV infection and vaccination have almost
Table 3: Parents' and children's knowledge of HPV infection and vaccination, by gender.
Parents Students
Mothers Fathers P value1 Females Males P value2
No. % No. % No. % No. %
Have you ever heard of HPV?
No/Do not know 110 9.0 259 23.7 184 28.4 102 48.8
Yes 1115 91.0 834 76.9 <0.001 465 71.6 107 51.2 <0.001
Do you think HPV infection can be dangerous?
Yes 1026 92.0 735 88.1 421 90.5 96 89.7
No/Only when other health conditions are present/
Do not know
89 8.0 99 11.9 0.004 44 9.5 11 10.3 0.80
Do you know how HPV infection is passed on?
Sexual intercourse 1049 94.1 762 91.4 421 90.5 99 92.5
Wrong answers/Do not know 66 5.9 72 8.6 0.02 44 9.5 8 7.5 0.52
What is the aim of HPV vaccination?
To prevent cervical cancer
Yes 1005 90.1 723 86.7 350 75.3 67 62.6
No/Do not know 110 9.9 111 13.3 0.02 1 1 5 2 4 . 74 03 7 . 4 0.008
To prevent a STD
Yes 104 9.3 100 12.0 56 12.0 15 14.0
No/Do not know 1011 90.7 734 88.0 0.06 409 88.0 92 86.0 0.58
When should HPV vaccination be given?3
During the first year of life 36 3.2 25 3.0 0.77 14 3.0 3 2.8 1.00
Before sexual activity begins 852 76.4 621 74.5 0.32 351 75.5 72 67.3 0.08
After sexual activity has begun 57 5.1 48 5.8 0.53 37 8.0 8 7.5 0.87
STD, sexually transmitted disease. 1 Mothers vs fathers. 2 Females vs males. 3 As multiple answers were allowed, each was considered a 
dichotomous variable (yes/no); the numbers do not add up to the total because infrequent answers are not included.Pelucchi et al. BMC Public Health 2010, 10:378
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exclusively been publicised in relation to the prevention
of cervical cancer, and it is still being discussed whether
males should also be vaccinated [39,40]. Teenagers of
both sexes therefore need further information.
We found that the attitude of both parents to vaccina-
tions was very positive, not only because the overwhelm-
ing majority were in favour of vaccination in general, but
also because about two-thirds said they were in favour of
a new vaccination against HPV, even though complete
data on the vaccine are not yet available. Fewer than 7% of
the parents declared they were certainly against the vacci-
nation, and similarly encouraging results were found
among the female students. It is interesting to note that
47% of the parents named pediatricians as their preferred
counsellor in the case of decisions concerning vaccina-
tions, and 65% of those with children aged aged <12
years. The recommendation of other physicians (mainly
family doctors) was important for 26%, and so these
might also play a major role in decision making. In agree-
ment with previous studies [41-45], these data suggest
that programmes aimed at increasing vaccination cover-
age should also involve pediatricians or family physicians
depending on the age of the target.
Another finding was that parents consider the indica-
tions of the Ministry of Health (48%) rather than Regional
institutions (about 3%) as a reference for decision mak-
ing. This highlights the fact that the general population
does not realise that recommendations concerning vac-
cines (and the availability of free vaccinations) is deter-
mined not centrally but at Regional level in Italy.
Table 4: Parents' and students' attitude to vaccination, by gender.
Parents Students
Mothers Fathers P value1 Females Males P value2
No. % No. % No. % No. %
Are you in favour of vaccinations in general? 3,4
No 97 8.0 72 6.7
Yes 1117 92.0 1009 93.3 0.22
Whose recommendations are significant to you 
when deciding on a vaccination for your 
children? 3,5
Ministry of Health 594 48.5 518 47.4 0.60
Regional body 41 3.3 43 3.9 0.45
Pediatrician 614 50.1 475 43.5 0.001
Other physician 343 28.0 268 24.5 0.06
Relative or friend 20 1.6 16 1.5 0.74
Teacher 5 0.4 7 0.6 0.44
Religious authority 6 0.5 4 0.4 0.65
Other 78 6.4 77 7.0 0.51
Do you think HPV infection might concern your 
children (for parents)/you (for students)? 4
Do not know 251 20.7 286 26.6 174 27.1 65 31.1
No 255 21.0 219 20.3 179 27.9 89 42.6
Yes 707 58.3 572 53.1 0.004 2 8 9 4 5 . 05 52 6 . 3 <0.001
Would you give your children (for parents)/
undergo (for students) HPV vaccination HPV? 4
No 92 7.6 66 6.1 36 5.6 40 19.1
Perhaps 293 24.1 308 28.7 169 26.1 86 41.1
Yes 830 68.3 699 65.1 0.03 4 4 2 6 8 . 38 33 9 . 7 <0.001
1 Mothers vs fathers. 2 Female students vs male students. 3 Question for parents only. 4 The numbers do not add up to the total because of a few 
missing answers. 5 As multiple answers were allowed, each was considered a dichotomous variable (yes/no).Pelucchi et al. BMC Public Health 2010, 10:378
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Table 5: Associations between selected socio-demographic factors, personal beliefs and attitudes of parents to 
vaccinating their children against HPV.
In favour of HPV vaccination (n = 1438) Against or doubtful about 
HPV vaccination (n = 706)
OR (95% CI) 2
No. % No. %
Age of parent (years)
<40 80 5.6 37 5.2 1 (reference)
40-44 319 22.2 172 24.4 0.85 (0.54-1.31)
45-49 565 39.3 265 37.5 1.04 (0.67-1.60)
≥50 474 33.0 232 32.9 1.05 (0.68-1.64)
Education
Middle school diploma 254 17.7 122 17.3 1 (reference)
High school diploma 616 42.8 280 39.7 1.04 (0.80-1.35)
Degree 568 39.5 304 43.1 0.91 (0.69-1.19)
Parent
Father 658 45.8 347 49.1 1 (reference)
Mother 780 54.2 359 50.8 1.17 (0.97-1.42)
Religion
Catholic 1314 91.4 608 86.1 1 (reference)
Other/no religion 124 8.6 98 13.9 0.61 (0.46-0.82)
Age of (youngest) child involved in the study 
(years)
<12 164 11.4 82 11.6 1 (reference)
12-14 434 30.2 218 30.9 1.04 (0.76-1.43)
≥15 840 58.4 406 57.5 0.93 (0.69-1.26)
Gender of child(ren) involved in the study
Male(s) only 336 23.4 255 36.1 1 (reference)
At least one daughter 1102 76.6 451 63.9 1.88 (1.53-2.30)
Generally in favour of vaccinations 3
No 17 1.2 139 20.0 1 (reference)
Yes 1416 98.8 555 80.0 23.1 (13.7-38.8)
Knows that HPV vaccine is aimed at 
preventing cervical cancer 3
No/Does not know 107 8.3 91 17.0 1 (reference)
Yes 1179 91.7 444 83.0 2.31 (1.69-3.16)
Thinks that HPV might concern own 
child(ren) 3
No/Does not know 487 34.0 449 64.0 1 (reference)
Yes 946 66.0 253 36.0 3.52 (2.89-4.29)
CI, confidence interval; OR = odds ratio. 1 The numbers of subjects are not the same as in Table 4 because those with missing information relating 
to one or more of the socio-demographic covariates in the models (n = 187; 8% of the total) were excluded. 2 ORs from multivariate logistic 
regression models, adjusted for age, education, gender and religion of parent, and age and gender of the child. 3 The numbers do not add up to 
the total because of missing answers.Pelucchi et al. BMC Public Health 2010, 10:378
http://www.biomedcentral.com/1471-2458/10/378
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Table 6: Association between selected socio-demographic factors, personal beliefs and characteristics, and attitudes of 
students to being vaccinated against HPV, by gender.1
Males Females
In favour of 
HPV vaccination 
(n = 78)
Against or 
doubtful about 
HPV vaccination 
(n = 123)
OR (95% CI) 2 In favour of HPV
 vaccination 
(n = 431)
Against or 
doubtful about 
HPV vaccination 
(n = 196)
OR (95% CI) 2
No. (%) No. (%) No. (%) No. (%)
Age (years)
<16 29 (37.2) 55 (44.7) 1 (reference) 156 (36.2) 72 (36.7) 1 (reference)
16-17 37 (47.4) 51 (41.5) 1.40 (0.75-2.61) 198 (45.9) 100 (51.0) 0.95 (0.65-1.37)
≥18 12 (15.4) 17 (13.8) 1.38 (0.58-3.31) 77 (17.9) 24 (12.2) 1.51 (0.88-2.59)
Religion
Catholic 66 (84.6) 100 (81.3) 1 (reference) 382 (88.6) 165 (84.2) 1 (reference)
Other/no religion 12 (15.4) 23 (18.7) 0.77 (0.35-1.66) 49 (11.4) 31 (15.8) 0.67 (0.41-1.10)
Highest education 
qualification of parents
Middle school diploma 7 (9.0) 11 (8.9) 1 (reference) 55 (12.8) 30 (15.3) 1 (reference)
High school diploma 23 (29.5) 38 (30.9) 0.94 (0.32-2.80) 177 (41.1) 82 (41.8) 1.13 (0.67-1.91)
Degree 48 (61.5) 74 (60.2) 1.06 (0.38-2.97) 199 (46.2) 84 (42.9) 1.27 (0.76-2.14)
Thinks that HPV might 
concern him/her3
No/Does not know 42 (53.8) 106 (86.2) 1 (reference) 207 (48.7) 136 (69.7) 1 (reference)
Yes 36 (46.1) 17 (13.8) 5.73 (2.85-11.5) 218 (51.3) 59 (30.3) 2.39 (1.66-3.46)
Has a boyfriend/
girlfriend 3
No 52 (66.7) 83 (69.7) 1 (reference) 283 (65.8) 113 (57.6) 1 (reference)
Yes 26 (33.3) 36 (30.2) 1.16 (0.62-2.17) 147 (34.2) 83 (42.3) 0.67 (0.47-0.97)
Has had sexual 
intercourse 3
No 55 (70.5) 90 (76.3) 1 (reference) 335 (78.3) 142 (72.4) 1 (reference)
Yes 23 (29.5) 28 (23.7) 1.30 (0.65-2.62) 93 (21.7) 54 (27.5) 0.68 (0.44-1.03)
Knows that HPV 
vaccine is aimed at 
preventing cervical 
cancer 3
No/Does not know 17 (44.7) 23 (35.9) 1 (reference) 75 (23.1) 36 (28.3) 1 (reference)
Yes 21 (55.3) 41 (64.1) 0.69 (0.30-1.61) 249 (76.8) 91 (71.6) 1.26 (0.79-2.03)
CI = confidence interval; OR = odds ratio. 1 The numbers of subjects are not the same as in Table 4 because those with missing information 
relating to one or more of the socio-demographic covariates in the models (n = 35; 4% of the total) were excluded. 2 ORs from multivariate logistic 
regression models, adjusted for age and religion of child, and education of parents. 3 The numbers do not add up to the total because of missing 
answers.Pelucchi et al. BMC Public Health 2010, 10:378
http://www.biomedcentral.com/1471-2458/10/378
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The main factors associated with the parents' propen-
sity to accept HPV vaccination were: 1) having at least
one daughter; 2) being in favour of vaccinations in gen-
eral; 3) knowing that the vaccine is aimed at preventing
cervical cancer; and 4) being aware that their children
could be infected by HPV (this association was particu-
larly strong). As also found by other studies [46-49], there
was also a positive association between the perceived
likelihood of HPV infection and the propensity of both
male and female students to undergo vaccination [46-49].
This supports that the first target for the success of HPV
vaccination campaign should be to increase adolescents'
and parents' knowledge on this topic, particularly under-
lining the frequency of HPV. Although the association
was not statistically significant, our findings also indi-
cated that mothers were more likely to favour having
their children vaccinated than fathers. When all of these
analyses were limited to the parents of daughters alone,
the results were substantially the same.
In addition to their awareness of possible HPV infec-
tion, a few other factors were also associated with the
propensity of students to undergo vaccination. In partic-
ular, having a boyfriend or having already had sexual
intercourse were associated with a decreased propensity
among female students, possibly because of the high pro-
portion who knew the vaccination should be given before
the start of sexual activity. However, this highlights the
need for a training programme focused on the epidemiol-
ogy of HPV infection in different age groups and the risk
factors associated with acquiring it, in order to show that
vaccination can also be useful even after the beginning of
sexual activity provided that the infection has not already
been acquired.
The limitations of this study include the fact that our
sample was not representative of the general Italian pop-
ulation, recruitment was limited to one Italian Region, a
convenience sample of schools was selected and mainly
upper-middle class population was included. Though the
proportion of respondents to the survey was satisfactorily
high, those with higher knowledge and interested by
HPV-related health problems were more likely to partici-
pate in the study. These considerations are reflected by
the high level of education of parents (i.e., about 40% had
a university degree, as compared to 24% in the general
Milan population [50]) and larger number of female than
male students participating to the survey. However, when
we corrected our results for educational level of the par-
ents using post-stratification weights [51], the major find-
ings were only marginally different (e.g., the corrected
proportion of mothers and fathers who had ever heard of
HPV were 88% and 75%, respectively). In addition, we
could not obtain information from middle school chil-
dren (i.e. those aged 10-13 years) because their school
boards considered them to be too young. On the con-
trary, the major strengths of the study are its large size,
the availability of concurrent information from both par-
ents and children, and the inclusion of both male and
female subjects.
Conclusions
In conclusion, our data highlight the fact that a better
understanding of HPV infection and the possibility of
preventing cancer by means of HPV vaccination could
increase the acceptance of vaccination by both students
and parents. This underlines the need to plan adequate
educational programs. Moreover, as physicians (both
pediatricians and family physicians) can play a critical
role in counseling, their knowledge of HPV infection and
its prevention should also be evaluated and improved if
necessary.
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